Anisodine Hydrobromide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anisodine Hydrobromide, covering 2024-02-28 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) [Phase 1]